Sonendo, Inc.

Laguna Hills, CA · Founded 2006 · CIK 0001407973 · Medtech · Public

Endodontic treatment system using continuous, closed-system, near-body temperature fluid dynamics to clean and fill root canals

sonendo.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$238M
14 Form D · May 2025
17 months since last filing
Contracts
—
No federal contracts on record
Patents
40
18 granted · 22 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$500,000
Private capital raisedForm D · SEC$718,000
Private capital raisedForm D · SEC$2,131,871
Private capital raisedForm D · SEC$9,209,998
Private capital raisedForm D · SEC$18,000,000
Private capital raisedForm D · SEC$3,090,000
Private capital raisedForm D · SEC$35,000,007
Private capital raisedForm D · SEC$33,266,395
Private capital raisedForm D · SEC$4,000,006
Private capital raisedForm D · SEC$850,000
Private capital raisedForm D · SEC$24,999,986
Private capital raisedForm D · SEC$17,000,005
Private capital raisedForm D · SEC$84,699,923
Private capital raisedForm D · SEC$5,000,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1354RAYLIFE INC.——
1355NEOGENOMICS INC—$500K
1356VIVARAY INC—$600K
1357Sonendo, Inc.—$238M
1358LAP IQ, INC.——
1359Alaunus Biosciences——
1360CONSENSUS NETWORKS INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 25 related persons
  • Erik AmbleDirector
  • Brooks AndrewsDirector
  • Carolyn BeaverDirector
  • Bjarne BergheimDirector · Executive Officer
  • Olav BergheimDirector · Executive Officer
  • Anthony Bihl IIIDirector
  • John BostjancicExecutive Officer
  • Vince BurgessDirector
  • David CaluoriDirector
  • Roy CosanDirector
  • Kevin CousinsExecutive Officer
  • Alex CrissesDirector
  • Cory EavesDirector
  • Thomas EngelsDirector
  • Daniel EvenDirector
  • Morteza GharibDirector
  • John GlennExecutive Officer
  • Scott HuennekensDirector
  • Paul MaderaDirector
  • John McGaughExecutive Officer
  • Hugh NeuharthExecutive Officer
  • Raj PudipeddiDirector
  • Michael WattsExecutive Officer
  • Fan YuDirector
  • Michael ZhaoDirector

Patents

USPTO · 18 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.